Literature DB >> 19784964

PTEN-mediated G1 cell-cycle arrest in LNCaP prostate cancer cells is associated with altered expression of cell-cycle regulators.

P W van Duijn1, A C J Ziel-van der Made, J A G van der Korput, J Trapman.   

Abstract

BACKGROUND: The tumor suppressor PTEN regulates many biological processes. A well-known downstream effector of PTEN is phospho-Akt. Although PTEN is the most frequently inactivated gene in prostate cancer, its mode of action is not fully understood. We studied the association of regulated PTEN expression with changes in biological function and gene expression profiles.
METHODS: PTEN-negative LNCaP cells were stably transfected with wild-type PTEN cDNA under inducible control, resulting in LNCaP/PTEN cells. Microarray analysis was used to monitor gene expression changes upon induction of PTEN. Expression of selected individual genes was studied in Q-PCR and siRNA experiments. Cell-cycle distribution was analyzed by flow cytometry.
RESULTS: Induced expression of PTEN in LNCaP/PTEN cells significantly inhibited cell proliferation, at least partly due to cell-cycle arrest at the G1 phase. Expression profiling combined with pathway analysis revealed that PTEN-dependent G1 growth arrest was associated with an altered mRNA expression of the G1 cell-cycle regulators Cdc25a, E2F2, cyclin G2, and RBL2/p130. Specific inhibition of Akt signaling by siRNA resulted in downregulation of both E2F2 and Cdc25a mRNA expression and upregulation of the FOXO target cyclin G2, similar to the effect observed by PTEN induction. However, Akt did not mediate the PTEN-dependent RBL2/p130 mRNA expression in LNCaP/PTEN cells.
CONCLUSIONS: The results indicate that PTEN dependent gene expression is important in cell-cycle regulation and is mediated by both Akt-dependent and -independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19784964     DOI: 10.1002/pros.21045

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  19 in total

1.  The chaperone-assisted E3 ligase C terminus of Hsc70-interacting protein (CHIP) targets PTEN for proteasomal degradation.

Authors:  Syed Feroj Ahmed; Satamita Deb; Indranil Paul; Anirban Chatterjee; Tapashi Mandal; Uttara Chatterjee; Mrinal K Ghosh
Journal:  J Biol Chem       Date:  2012-03-15       Impact factor: 5.157

2.  Combined haploinsufficiency and genetic control of the G2/M checkpoint in irradiated cells.

Authors:  Erik F Young; Lubomir B Smilenov; Howard B Lieberman; Eric J Hall
Journal:  Radiat Res       Date:  2012-05-18       Impact factor: 2.841

3.  Proteomics analyses of prostate cancer cells reveal cellular pathways associated with androgen resistance.

Authors:  Naseruddin Höti; Punit Shah; Yingwei Hu; Shuang Yang; Hui Zhang
Journal:  Proteomics       Date:  2017-03       Impact factor: 3.984

4.  Prodrug strategy for PSMA-targeted delivery of TGX-221 to prostate cancer cells.

Authors:  Yunqi Zhao; Shaofeng Duan; Xing Zeng; Chunjing Liu; Neal M Davies; Benyi Li; M Laird Forrest
Journal:  Mol Pharm       Date:  2012-05-01       Impact factor: 4.939

5.  Changes in the expression of cyclin G2 in esophageal cancer cell and its significance.

Authors:  J Q Chen; C J Liu; H X Wen; C L Shi; H S Zhang; M Li; G G Sun
Journal:  Tumour Biol       Date:  2013-12-03

6.  Effect of cyclin G2 on proliferative ability of prostate cancer PC-3 cell.

Authors:  D W Cui; Y J Cheng; S W Jing; G G Sun
Journal:  Tumour Biol       Date:  2013-11-29

7.  Regulatory Effects and Mechanism of Adenovirus-Mediated PTEN Gene on Hepatic Stellate Cells.

Authors:  Junyan An; Libo Zheng; Shurui Xie; Fengrong Yin; Xiaoxia Huo; Jian Guo; Xiaolan Zhang
Journal:  Dig Dis Sci       Date:  2015-12-12       Impact factor: 3.199

8.  CCNG2 expression is downregulated in colorectal carcinoma and its clinical significance.

Authors:  G G Sun; J Zhang; W N Hu
Journal:  Tumour Biol       Date:  2013-12-03

9.  Decreased expression of CCNG2 is significantly linked to the malignant transformation of gastric carcinoma.

Authors:  G G Sun; W N Hu; D W Cui; J Zhang
Journal:  Tumour Biol       Date:  2013-11-19

10.  Change in expression of cyclin G2 in kidney cancer cell and its significance.

Authors:  D W Cui; G G Sun; Y J Cheng
Journal:  Tumour Biol       Date:  2013-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.